Medicure Inc. (OTCMKTS:MCUJF) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.91 and traded as low as $0.64. Medicure shares last traded at $0.64, with a volume of 11,000 shares traded.
The firm has a market capitalization of $6.82 million, a price-to-earnings ratio of -0.53 and a beta of 0.25. The company has a current ratio of 3.39, a quick ratio of 2.50 and a debt-to-equity ratio of 0.03. The firm has a fifty day moving average price of $0.78 and a 200 day moving average price of $0.90.
Medicure Company Profile (OTCMKTS:MCUJF)
Medicure Inc, a cardiovascular pharmaceutical company, engages in the research, clinical development, and commercialization of human therapeutics in Canada, the United States, and Barbados. The company primarily markets and sells AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction, as well as AGGRASTAT high-dose bolus regimen for the reduction of thrombotic cardiovascular events in patients with non ST elevated acute coronary syndrome.
Recommended Story: Buyback
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.